Same-Day Restart of B/F/TAF in HIV Patients After NNRTI Discontinuation

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

February 28, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
HIV InfectionHIV
Interventions
DRUG

Regimen:BIC+FTC+TAF

"Same-day restart of BIC+FTC+TAF among HIV patients who experienced discontinuation from previous NNRTI-based regimens"

Trial Locations (1)

102206

National Center for AlDS/STD Control and Prevention,China CDC,NO.155, Changbai Road,Changping District,Beijing, Chian

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Gilead Sciences

INDUSTRY

lead

National Center for AIDS/STD Control and Prevention, China CDC

OTHER_GOV

NCT06830668 - Same-Day Restart of B/F/TAF in HIV Patients After NNRTI Discontinuation | Biotech Hunter | Biotech Hunter